Live Breaking News & Updates on Almirall Partnership

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Athenex Announces U.S. Launch of Klisyri® and Licensing of Additional Territories for Tirbanibulin
Athenex, Inc.February 18, 2021 GMT
Athenex Announces Licensing of Additional Territories for the Development and Commercialization of Tirbanibulin in Japan and South Korea.
PharmaEssentia Expands Tirbanibulin Partnership by Adding Japan and South Korea to Already Licensed Territories of Taiwan, Singapore, and Malaysia
Athenex’s Existing Partners Include Almirall, S.A., in the United States, Europe, and Russia; and Guangzhou Xiangxue Pharmaceutical in China
Almirall launches Klisyri® for actinic keratosis in the U.S. today ....

New York , United States , Hong Kong , United Kingdom , Republic Of , T Ai Pei , New Jersey , Guatemala City , South Korea , Buenos Aires , Distrito Federal , South Korean , Daniel Lang , Ko Chung Lin , Johnson Lau , Gloria Gasaatura , Steve Rubis , Tim Mccarthy , Taiwan Exchange , Lifesci Advisors , Almirall Partnership , Investor Relations Department , Drug Administration , Athenex Inc , Pharmaessentia Expands Tirbanibulin Partnership , Lifesci Communications ,